Esprinet cautiously optimistic following Q3 amid challenging macroeconomic climate

Italian distributor Esprinet says it is cautiously optimistic for the future following its third quarter 2022 financial results.  Sales were up seven per cent year on year to €1.039bn in Q3. Whereas EBIT dropped seven per cent to €10m for the quarter.  "We close the first nine months of the year with results that confirm the structural approach of the 2022 budget: a first half which reflected a challenging comparison with 2021, which had enjoyed still sustained demand and healthy pro...